Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Akums Drugs And Pharmaceuticals Limited, is an unlisted public company incorporated on 19 April, 2004. It is classified as a public limited company and is located in Delhi, Delhi. It's authorized share capital is INR 40.00 cr and the total paid-up capital is INR 31.48 cr.
Akums Drugs And Pharmaceuticals Limited's operating revenue range is Over INR 500 cr for the financial year ending on 31 March, 2024. It's EBITDA has decreased by 152.36% over the previous year. At the same time, it's book networth has decreased by 53.81%.
Read more
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Kewal Kundanlal Handa | 00056826 | 3 years |
Director | Satwinder Singh | 00164903 | 1 years |
Managing Director | Sanjeev Jain
Shareholder
|
00323433 | 21 years |
Managing Director | Sandeep Jain
Shareholder
|
00323476 | 21 years |
Director | Matangi Gowrishankar | 01518137 | 3 years |
Nominee Director | Sunil Kumar Thakur | 03266370 | 1 years |
Whole-time Director | Sanjay Sinha | 03627342 | 1 years |
Director | Nand Lal Kalra | 05268554 | 13 years |
CS | Dharamvir Malik | <HIDDEN> | 11 years |
CFO | Sumeet Sood | <HIDDEN> | 3 years |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
SBICap Trustee Company Limited
No. of Loans: 1
Total Amount : 305.0 cr
Oriental Bank of Commerce
No. of Loans: 1
Total Amount : 0.2 cr
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
PURE AND CURE HEALTHCARE PRIVATE LIMITED | Delhi | 2005 | ₹ 3.0 Cr |
MALIK LIFESCIENCES PRIVATE LIMITED | Delhi | 2004 | ₹ 46.7 L |
MAXCURE NUTRAVEDICS LIMITED | Delhi | 1994 | ₹ 5.5 L |
AKUMENTIS HEALTHCARE LIMITED | Delhi | 2010 | ₹ 11.5 L |
UNOSOURCE PHARMA LIMITED | Delhi | 2013 | ₹ 18.0 Cr |
DELCURE LIFESCIENCES LIMITED | Delhi | 2013 | ₹ 50.0 L |
AMAZING RESEARCH LABORATORIES LIMITED | Delhi | 1998 | ₹ 5.0 L |
PLENTEOUS PHARMACEUTICALS LIMITED | Delhi | 2008 | ₹ 5.0 L |
MAY AND BAKER PHARMACEUTICALS LIMITED | Delhi | 2006 | ₹ 5.0 L |
NICHOLAS HEALTHCARE LIMITED | Delhi | 2009 | ₹ 10.8 L |
Read more
The incorporation date of AKUMS DRUGS AND PHARMACEUTICALS LIMITED is 19 April, 2004
The authorized share capital of AKUMS DRUGS AND PHARMACEUTICALS LIMITED is INR ₹ 40.0 Cr.
The paid-up capital of AKUMS DRUGS AND PHARMACEUTICALS LIMITED is INR ₹ 31.5 Cr.
The registered address of AKUMS DRUGS AND PHARMACEUTICALS LIMITED is 304 MOHAN PLACELSC SARASWATI VIHAR NA DELHI Delhi - 110034
The CIN number of AKUMS DRUGS AND PHARMACEUTICALS LIMITED is U24239DL2004PLC125888.